FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer
At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported the…
Browsing Tag
Inhibitor
Some NSCLC Patients on ICI Therapy Fare Worse With Proton Pump Inhibitor Use
Proton pump inhibitor (PPI) use was independently associated with worse…
GT Apeiron Announces Enrollment of First Patient in Phase 1/2 “ELUCIDATE” Clinical…
- Preclinical data from AI-optimized GTAEXS617 support potential for improved therapeutic index compared to other CDK7 inhibitors under development - - Parallel translational initiative to…
HUTCHMED Initiates Phase I Study of its novel SHP2 inhibitor HMPL-415 for Advanced…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 09, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has…
Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLL
The non-covalent or reversible Bruton tyrosine kinase (BTK) inhibitor…
EphrinB2 Expression in Urothelial Cancer Tied to Checkpoint Inhibitor Activity
A prior analysis of data from The Cancer Genome Atlas (TCGA) demonstrated that high EphrinB2…
First Oral JAK Inhibitor Approved for Severe Alopecia Areata in Teens
The FDA approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for…
Erasca Granted FDA Orphan Drug Designation for CNS-Penetrant EGFR Inhibitor ERAS-801…
ERAS-801 has now received ODD in addition to FDA Fast Track Designation Initial THUNDERBBOLT-1 Phase 1 monotherapy data in patients with recurrent GBM expected in H2 2023 SAN DIEGO, June…
Cyclin-Dependent Kinase Inhibitor Clinical Trial Pipeline: DelveInsight Highlights…
New York, USA, June 21, 2023 (GLOBE NEWSWIRE) -- Cyclin-Dependent Kinase Inhibitor Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 50+…
First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes
Two empagliflozin-containing treatments were FDA approved for pediatric type 2…